Precipio (NASDAQ:PRPO – Get Free Report) and Community Health Systems (NYSE:CYH – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.
Valuation & Earnings
This table compares Precipio and Community Health Systems”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Precipio | $24.05 million | 1.44 | -$360,000.00 | ($0.64) | -30.23 |
| Community Health Systems | $11.65 billion | 0.03 | $509.00 million | $0.26 | 9.18 |
Community Health Systems has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Community Health Systems, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Precipio has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, Community Health Systems has a beta of 1.88, meaning that its stock price is 88% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings for Precipio and Community Health Systems, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
| Community Health Systems | 3 | 4 | 1 | 0 | 1.75 |
Community Health Systems has a consensus price target of $2.96, suggesting a potential upside of 23.99%. Given Community Health Systems’ stronger consensus rating and higher probable upside, analysts plainly believe Community Health Systems is more favorable than Precipio.
Insider & Institutional Ownership
10.4% of Precipio shares are held by institutional investors. Comparatively, 85.0% of Community Health Systems shares are held by institutional investors. 16.6% of Precipio shares are held by company insiders. Comparatively, 11.1% of Community Health Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Precipio and Community Health Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Precipio | -4.47% | -8.49% | -5.75% |
| Community Health Systems | 0.31% | -6.66% | -1.22% |
Summary
Community Health Systems beats Precipio on 11 of the 13 factors compared between the two stocks.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
About Community Health Systems
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. The company was incorporated in 1996 and is headquartered in Franklin, Tennessee.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
